India's GDP growth is projected to spike to a four-quarter high of 13 per cent in Q1 (April-June) FY23 due to a low base of Covid 2.0 and robust recovery in contact-intensive services, according to ICRA.
The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
EXAMIANS